Vivoryon Therapeutics N.V.

VVY.AS · AMS
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€9,365€18,562€26,555€14,661
Short-Term Investments€0€10,021€0€0
Receivables€312€495€3,965€3,360
Inventory€0€0€0€0
Other Curr. Assets€390€734€174€2,208
Total Curr. Assets€10,067€29,812€30,694€20,229
Property Plant & Equip (Net)€124€76€176€285
Goodwill€0€0€0€0
Intangibles€865€941€494€533
Long-Term Investments€0€0€14€3,473
Tax Assets€0€0€1€1
Other NC Assets€228€0-€1-€1
Total NC Assets€1,217€1,017€684€4,291
Other Assets€0€0€0€0
Total Assets€11,284€30,829€31,378€24,520
Liabilities
Payables€1,015€2,894€2,543€4,360
Short-Term Debt€120€76€188€184
Tax Payable€0€10€57€51
Deferred Revenue€0€0-€3-€4
Other Curr. Liab.€264€202€480€460
Total Curr. Liab.€1,399€3,182€3,265€5,051
LT Debt€42€0€38€132
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€234€432
Other NC Liab.€1,963€1,365€1,335€2,348
Total NC Liab.€2,005€1,365€1,607€2,912
Other Liabilities€0€0€0€0
Cap. Leases€102€38€132€224
Total Liabilities€3,404€4,547€4,872€7,963
Equity
Pref Stock€0€0€0€0
Common Stock€261€26,067€24,105€20,050
Retained Earnings-€169,367-€148,799-€120,457-€92,300
AOCI-€268€13,343-€180€5,596
Other Equity€177,254€135,671€123,038€83,211
Total Equity€7,880€26,282€26,506€16,557
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€11,284€30,829€31,378€24,520
Net Debt-€9,203-€18,486-€26,329-€14,345